Venture Capital

Belgian firm EDGX just put an AI brain in space. Its STERNA system promises to revolutionize data processing from orbit, with huge impacts on Earth.

A new non-profit has assembled leaders from Philips, Kearney, and more to standardize how companies navigate global volatility and integrate risk analysis.

AllRock Bio has begun a Phase 2a trial for its novel drug ROC-101, testing it in combination with new standard-of-care therapies for pulmonary hypertension.

Stova promotes Anupam Palit to CEO and tasks former chief Kirk Ziehm with AI, a strategic move to navigate industry consolidation and tech disruption.

A Swiss biotech's novel antibiotic has entered human trials with new funding, offering a fresh hope against the world's most dangerous superbugs.

A new paper warns that Lyme disease may pass from mother to child, a risk overlooked for decades. Researchers are now demanding urgent action and funding.

Sunon's CIFF 2026 showcase reveals a future where recyclable furniture, modular layouts, and robotic guides shape a smarter, greener, human-centric workplace.

Satri-cel, the world's first CAR-T therapy for solid tumors, is set to launch in China, offering a powerful new weapon against advanced stomach cancers.

Aptar Digital Health and Enable Injections are pairing the enFuse® wearable injector with a new digital app to transform self-care for chronic diseases.

With its reputation on the line, SF's top leaders are gathering for IDEASF, a new forum aiming to spark a city-wide renaissance. But can it deliver results?

The deal merges a leading health data platform with mobile diagnostics, aiming to remove barriers to proactive wellness and deliver lab tests anywhere.

A Texas firm opens a plant for a non-toxic chemical that boosts oil output and could turn old wells into a new source of critical minerals.

With its lead drug in Phase 3 and a strong Biogen partnership, Stoke Therapeutics prepares to update investors on its disease-modifying Dravet syndrome therapy.

As online reviews face a crisis of trust, a Bay Area company doubles down on a physical directory, betting that verified quality is worth its weight in paper.

Stratom's new TRAILS system will let Marines rapidly move 10,000-lb payloads under fire, boosting survivability in future conflicts.

After 30 years in entertainment, Character Media evolves to spotlight AAPI pioneers in business, tech, and leadership, launching a new era of influence.

Tekton Research launches its first multi-specialty clinical trial hub in San Antonio, leveraging top physician expertise to tackle diabetes and obesity.

Absci will showcase its generative AI drug discovery platform at a key healthcare conference, highlighting its ambitious pipeline for hair loss and endometriosis.

With stellar trial data for its cholesterol drug obicetrapib, NewAmsterdam Pharma faces investors as it navigates a competitive market and awaits key results.

Ovid Therapeutics is spotlighting a novel drug class targeting KCC2, a key brain protein. Could this be the key to treating psychosis and epilepsy?